Circulating tumor DNA predicts breast cancer relapse after treatment
Fragments of tumor DNA circulating in the bloodstream of patients with breast cancer can predict whether they are likely to relapse, especially when samples are taken after the patients have received treatments prior to surgery.
Linear Mode
